• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

比较 HIV 感染者中的控制者和非控制者肠道相关淋巴组织中的 HIV DNA 和 RNA。

Comparison of HIV DNA and RNA in gut-associated lymphoid tissue of HIV-infected controllers and noncontrollers.

机构信息

aDepartment of Medicine bDepartment of Epidemiology and Biostatistics, University of California cSan Francisco Veterans Affairs Medical Center, San Francisco, California, USA.

出版信息

AIDS. 2013 Sep 10;27(14):2255-60. doi: 10.1097/QAD.0b013e328362692f.

DOI:10.1097/QAD.0b013e328362692f
PMID:24157906
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4143147/
Abstract

OBJECTIVES

HIV-infected controllers have provided novel insights into mechanisms of viral control. We investigated the degree to which HIV DNA and RNA are present in gut-associated lymphoid tissue (GALT) of controllers.

DESIGN

Cross-sectional cohort study.

METHODS

Colorectal biopsy pieces were obtained from five untreated noncontrollers, five ART-suppressed patients, and nine untreated controllers.

RESULTS

Rectal HIV DNA was lower in controllers (median 496 copies/10(6) CD4 T cells) than in untreated noncontrollers (117483 copies/10(6) CD4+ T cells, P = 0.001) and ART-suppressed patients (6116 copies/10(6) CD4 T cells, P = 0.004). Similarly, rectal HIV RNA was lower in controllers (19 copies/10(6) CD4 T cells) than in noncontrollers (15210 copies/10(6) CD4+ T cells, P = 0.001) and ART-suppressed patients (1625 copies/10(6) CD4+ T cells, P = 0.0599). Rectal HIV RNA/DNA ratios were not statistically different between the three groups.

CONCLUSION

Despite being able to maintain very low plasma HIV RNA levels in the absence of antiretroviral therapy (ART), HIV-infected controllers have readily measurable levels of HIV DNA and RNA in GALT. As expected, controllers had lower rectal HIV DNA and RNA compared with untreated noncontrollers and ART-suppressed individuals. Compared with the mechanisms of 'natural' viral control of controllers, long-term ART does not reduce the total HIV reservoir to the level of controllers.

摘要

目的

HIV 感染者控制者为病毒控制机制提供了新的见解。我们研究了 HIV DNA 和 RNA 在肠道相关淋巴组织 (GALT) 中存在的程度。

设计

横断面队列研究。

方法

从五名未经治疗的非控制者、五名接受 ART 抑制的患者和九名未经治疗的控制者中获得直肠活检样本。

结果

控制者的直肠 HIV DNA 水平较低(中位数为 496 拷贝/10(6) CD4 T 细胞),低于未经治疗的非控制者(117483 拷贝/10(6) CD4+ T 细胞,P=0.001)和接受 ART 抑制的患者(6116 拷贝/10(6) CD4 T 细胞,P=0.004)。同样,控制者的直肠 HIV RNA 水平也较低(19 拷贝/10(6) CD4 T 细胞),低于非控制者(15210 拷贝/10(6) CD4+ T 细胞,P=0.001)和接受 ART 抑制的患者(1625 拷贝/10(6) CD4+ T 细胞,P=0.0599)。三组间直肠 HIV RNA/DNA 比值无统计学差异。

结论

尽管在没有抗逆转录病毒治疗 (ART) 的情况下能够维持非常低的血浆 HIV RNA 水平,但 HIV 感染的控制者的 GALT 中仍可检测到 HIV DNA 和 RNA。与未经治疗的非控制者和接受 ART 抑制的个体相比,控制者的直肠 HIV DNA 和 RNA 水平较低。与控制者的“天然”病毒控制机制相比,长期 ART 并未将总 HIV 储库降低到控制者的水平。

相似文献

1
Comparison of HIV DNA and RNA in gut-associated lymphoid tissue of HIV-infected controllers and noncontrollers.比较 HIV 感染者中的控制者和非控制者肠道相关淋巴组织中的 HIV DNA 和 RNA。
AIDS. 2013 Sep 10;27(14):2255-60. doi: 10.1097/QAD.0b013e328362692f.
2
Increased frequency of regulatory T cells accompanies increased immune activation in rectal mucosae of HIV-positive noncontrollers.HIV 阳性非感染者的直肠黏膜中调节性 T 细胞频率增加伴随免疫激活增强。
J Virol. 2011 Nov;85(21):11422-34. doi: 10.1128/JVI.05608-11. Epub 2011 Aug 31.
3
The Spontaneous Control of HIV Replication is Characterized by Decreased Pathological Changes in the Gut-associated Lymphoid Tissue.HIV复制的自发控制表现为肠道相关淋巴组织中病理变化减少。
Curr HIV Res. 2018;16(5):338-344. doi: 10.2174/1570162X17666190130115113.
4
Immunodominant HIV-specific CD8+ T-cell responses are common to blood and gastrointestinal mucosa, and Gag-specific responses dominate in rectal mucosa of HIV controllers.免疫优势 HIV 特异性 CD8+ T 细胞应答在血液和胃肠道黏膜中很常见,而 gag 特异性应答在 HIV 控制者的直肠黏膜中占主导地位。
J Virol. 2010 Oct;84(19):10354-65. doi: 10.1128/JVI.00803-10. Epub 2010 Jul 28.
5
HIV controllers with HLA-DRB1*13 and HLA-DQB1*06 alleles have strong, polyfunctional mucosal CD4+ T-cell responses.具有 HLA-DRB1*13 和 HLA-DQB1*06 等位基因的 HIV 控制器具有强大的、多功能的粘膜 CD4+ T 细胞反应。
J Virol. 2010 Nov;84(21):11020-9. doi: 10.1128/JVI.00980-10. Epub 2010 Aug 18.
6
Multiple measures of HIV burden in blood and tissue are correlated with each other but not with clinical parameters in aviremic subjects.血液和组织中多种HIV负担测量指标相互关联,但与病毒血症阴性受试者的临床参数无关。
AIDS. 2003 Jan 3;17(1):53-63. doi: 10.1097/00002030-200301030-00008.
7
The distribution of HIV DNA and RNA in cell subsets differs in gut and blood of HIV-positive patients on ART: implications for viral persistence.在接受抗逆转录病毒治疗的 HIV 阳性患者的肠道和血液中的细胞亚群中,HIV DNA 和 RNA 的分布不同:对病毒持续存在的影响。
J Infect Dis. 2013 Oct 15;208(8):1212-20. doi: 10.1093/infdis/jit308. Epub 2013 Jul 12.
8
Addition of cyclophosphamide to antiretroviral therapy does not diminish the cellular reservoir in HIV-infected persons.
AIDS Res Hum Retroviruses. 2002 May 20;18(8):535-43. doi: 10.1089/088922202753747888.
9
HIV-DNA in rectal cells is well correlated with HIV-DNA in blood in different groups of patients, including long-term non-progressors.在不同组别的患者中,包括长期不进展者,直肠细胞中的HIV-DNA与血液中的HIV-DNA具有良好的相关性。
AIDS. 2008 Sep 12;22(14):1880-2. doi: 10.1097/QAD.0b013e32830fbdbc.
10
Post-treatment control or treated controllers? Viral remission in treated and untreated primary HIV infection.治疗后控制还是接受治疗的控制者?初治和未治原发性HIV感染中的病毒缓解情况。
AIDS. 2017 Feb 20;31(4):477-484. doi: 10.1097/QAD.0000000000001382.

引用本文的文献

1
The intestinal interferon system and specialized enterocytes as putative drivers of HIV latency.肠道干扰素系统和特化肠上皮细胞作为HIV潜伏的潜在驱动因素。
Front Immunol. 2025 May 14;16:1589752. doi: 10.3389/fimmu.2025.1589752. eCollection 2025.
2
Combination immunotherapy induces post-intervention control of HIV.联合免疫疗法可诱导HIV的干预后控制。
Res Sq. 2025 Mar 19:rs.3.rs-6141479. doi: 10.21203/rs.3.rs-6141479/v1.
3
γδ T cells mediate robust anti-HIV functions during antiretroviral therapy regardless of immune checkpoint expression.在抗逆转录病毒治疗期间,γδ T细胞介导强大的抗HIV功能,而与免疫检查点表达无关。
Clin Transl Immunology. 2024 Jan 29;13(2):e1486. doi: 10.1002/cti2.1486. eCollection 2024.
4
Effects of Schistosoma mansoni and praziquantel treatment on the lower gastrointestinal mucosa: A cohort study in Tanzania.曼氏血吸虫和吡喹酮治疗对下消化道黏膜的影响:坦桑尼亚的一项队列研究。
Acta Trop. 2023 Feb;238:106752. doi: 10.1016/j.actatropica.2022.106752. Epub 2022 Nov 19.
5
CXCR3 Expression Pattern on CD4+ T Cells and IP-10 Levels with Regard to the HIV-1 Reservoir in the Gut-Associated Lymphatic Tissue.肠道相关淋巴组织中CD4+ T细胞上CXCR3的表达模式及IP-10水平与HIV-1储存库的关系。
Pathogens. 2022 Apr 18;11(4):483. doi: 10.3390/pathogens11040483.
6
Long-term immunologic effects of SARS-CoV-2 infection: leveraging translational research methodology to address emerging questions.SARS-CoV-2 感染的长期免疫学效应:利用转化研究方法解决新出现的问题。
Transl Res. 2022 Mar;241:1-12. doi: 10.1016/j.trsl.2021.11.006. Epub 2021 Nov 12.
7
Naive infection predicts reservoir diversity and is a formidable hurdle to HIV eradication.天真感染预测了储库多样性,是 HIV 根除的一个巨大障碍。
JCI Insight. 2021 Aug 23;6(16):e150794. doi: 10.1172/jci.insight.150794.
8
Predicting Post-treatment HIV Remission: Does Size of the Viral Reservoir Matter?预测治疗后HIV缓解:病毒储存库的大小重要吗?
Front Microbiol. 2021 Feb 26;12:648434. doi: 10.3389/fmicb.2021.648434. eCollection 2021.
9
The Emerging Role for CTL Epitope Specificity in HIV Cure Efforts.CTL 表位特异性在 HIV 治愈努力中的新作用。
J Infect Dis. 2021 Feb 15;223(12 Suppl 2):32-37. doi: 10.1093/infdis/jiaa333.
10
Safety, Immune, and Antiviral Effects of Pegylated Interferon Alpha 2b Administration in Antiretroviral Therapy-Suppressed Individuals: Results of Pilot Clinical Trial.聚乙二醇干扰素 α-2b 给药在抗逆转录病毒治疗抑制个体中的安全性、免疫和抗病毒效果:初步临床试验结果。
AIDS Res Hum Retroviruses. 2021 Jun;37(6):433-443. doi: 10.1089/AID.2020.0243. Epub 2021 Jan 29.

本文引用的文献

1
Cell-based measures of viral persistence are associated with immune activation and programmed cell death protein 1 (PD-1)-expressing CD4+ T cells.基于细胞的病毒持续存在测量与免疫激活和程序性细胞死亡蛋白 1(PD-1)表达的 CD4+T 细胞有关。
J Infect Dis. 2013 Jul;208(1):50-6. doi: 10.1093/infdis/jis630. Epub 2012 Oct 22.
2
Inhibition of HIV-1 integration in ex vivo-infected CD4 T cells from elite controllers.抑制精英控制者体内感染的 CD4 T 细胞中的 HIV-1 整合。
J Virol. 2011 Sep;85(18):9646-50. doi: 10.1128/JVI.05327-11. Epub 2011 Jul 6.
3
Elite suppressors harbor low levels of integrated HIV DNA and high levels of 2-LTR circular HIV DNA compared to HIV+ patients on and off HAART.与接受和未接受高效抗逆转录病毒治疗(HAART)的 HIV 阳性患者相比,精英抑制剂中整合的 HIV DNA 水平较低,而 2-LTR 环状 HIV DNA 水平较高。
PLoS Pathog. 2011 Feb;7(2):e1001300. doi: 10.1371/journal.ppat.1001300. Epub 2011 Feb 24.
4
The major genetic determinants of HIV-1 control affect HLA class I peptide presentation.HIV-1 控制的主要遗传决定因素影响 HLA Ⅰ类肽的呈递。
Science. 2010 Dec 10;330(6010):1551-7. doi: 10.1126/science.1195271. Epub 2010 Nov 4.
5
Differences in HIV burden and immune activation within the gut of HIV-positive patients receiving suppressive antiretroviral therapy.在接受抑制性抗逆转录病毒治疗的 HIV 阳性患者的肠道内,HIV 负担和免疫激活存在差异。
J Infect Dis. 2010 Nov 15;202(10):1553-61. doi: 10.1086/656722. Epub 2010 Oct 12.
6
Effect of raltegravir-containing intensification on HIV burden and T-cell activation in multiple gut sites of HIV-positive adults on suppressive antiretroviral therapy.在接受抑制性抗逆转录病毒治疗的 HIV 阳性成年人的多个肠道部位,含拉替拉韦的强化治疗对 HIV 负荷和 T 细胞激活的影响。
AIDS. 2010 Oct 23;24(16):2451-60. doi: 10.1097/QAD.0b013e32833ef7bb.
7
Immunodominant HIV-specific CD8+ T-cell responses are common to blood and gastrointestinal mucosa, and Gag-specific responses dominate in rectal mucosa of HIV controllers.免疫优势 HIV 特异性 CD8+ T 细胞应答在血液和胃肠道黏膜中很常见,而 gag 特异性应答在 HIV 控制者的直肠黏膜中占主导地位。
J Virol. 2010 Oct;84(19):10354-65. doi: 10.1128/JVI.00803-10. Epub 2010 Jul 28.
8
Death rates in HIV-positive antiretroviral-naive patients with CD4 count greater than 350 cells per microL in Europe and North America: a pooled cohort observational study.在欧洲和北美的 HIV 阳性、未接受过抗逆转录病毒治疗的、CD4 计数大于 350 个细胞/微升的患者中,死亡率:一项汇总队列观察性研究。
Lancet. 2010 Jul 31;376(9738):340-5. doi: 10.1016/S0140-6736(10)60932-4. Epub 2010 Jul 15.
9
Control of HIV-1 in elite suppressors despite ongoing replication and evolution in plasma virus.精英控制者体内尽管存在持续的血浆病毒复制和演变,但仍能控制 HIV-1。
J Virol. 2010 Jul;84(14):7018-28. doi: 10.1128/JVI.00548-10. Epub 2010 May 5.
10
Persistent low-level viremia in HIV-1 elite controllers and relationship to immunologic parameters.HIV-1精英控制者的持续性低水平病毒血症及其与免疫参数的关系。
J Infect Dis. 2009 Sep 15;200(6):984-90. doi: 10.1086/605446.